Diabetes News and Research

Latest Diabetes News and Research

Cuffless monitor offers promise for hypertension management

A study led by a Brigham investigator evaluated a novel device that automatically measures blood pressure at the wrist, generating hundreds of readings within days that may help clinicians determine cardiovascular risk and improve hypertension care

26 Jun 2024

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Researchers compare the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics.

26 Jun 2024

Study finds women lost more of their body weight on average with semaglutide than men

Researchers performed a secondary analysis of the semaglutide treatment effect in people with obesity and heart failure with a preserved left ventricular ejection fraction program that included individuals with diabetes mellitus, stratified by biological sex.

26 Jun 2024

Higher intake of ultra-processed foods found to increase cancer mortality risk

The association between ultra-processed food (UPF) consumption and gastrointestinal (GI) cancers.

26 Jun 2024

New drug tirzepatide significantly improves sleep apnea and weight loss

The effects of tirzepatide on adults with obesity and moderate-to-severe obstructive sleep apnea.

26 Jun 2024

Dietary fiber promotes beneficial conversion of tryptophan by gut bacteria

We get healthy dietary fibres from consuming fruits, vegetables, and whole grains. But why are the fibres so good for us? A team of researchers has discovered that dietary fibres play a crucial role in determining the balance between the production of healthy and harmful substances by influencing the behavior of bacteria in the colon.

26 Jun 2024

Study offers insights into gut microbiome diversity and type 2 diabetes risk

Brigham, Broad and Harvard Chan School researchers found that specific species and strains of bacteria were linked to changes in the functioning of the gut microbiome and a person's risk of type 2 diabetes.

26 Jun 2024

Research finds increased cancer risk in diabetic adults aged 40-54 years

Diabetes significantly increases the risk of cancer, particularly in people aged 40-54 years, new research shows.

26 Jun 2024

Empathy intensifies negative health effects of conflict for kids

Children who report being more empathetic are more likely to show signs of poorer health in the face of more interparental conflict than less empathetic children, according to a new study led by researchers in the Penn State College of Health and Human Development.

26 Jun 2024

Hospital-based donor care linked to longer lung transplant survival rates

A new study by Penn researchers examined, for the first time, the differences in lung transplant graft outcomes from organs recovered from the two types of deceased organ donor care facilities operating in the United States. The research, published today in JAMA Network Open, offers insights that could improve the organ donation and transplantation process for patients across the nation.

26 Jun 2024

Study provides resource for investigating diabetes-linked transcription factors

Scientists have generated a comprehensive map of the gene targets regulated by the transcription factors HNF4A and HNF1A in human pancreatic beta cells and liver cells. Published in the journal Nature Communications, the study revealed common and tissue-specific molecular pathways regulated by HNF4A and HNF1A, two proteins that possess important functions governing the development and function of the pancreas and liver.

26 Jun 2024

Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties, according to research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024.

26 Jun 2024

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

The SELECT trial found that semaglutide significantly reduces cardiovascular events in individuals with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or changes in HbA1c levels.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

Innovative insulin algorithm enhances glucose control for hospitalized patients

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar.

25 Jun 2024

Study reveals brain health benefits of intermittent fasting and healthy diet plans

Researchers from Johns Hopkins Medicine and the National Institutes of Health's National Institute on Aging say their study of 40 older adults with obesity and insulin resistance who were randomly assigned to either an intermittent fasting diet or a standard healthy diet approved by the U.S. Department of Agriculture (USDA) offers important clues about the potential benefits of both eating plans on brain health.

25 Jun 2024

Los Angeles County approves medical debt relief for residents

Los Angeles County supervisors voted unanimously Tuesday to buy up and forgive millions of dollars in medical debt as part of a comprehensive plan to tackle a $2.9 billion burden that weighs on almost 800,000 residents.

25 Jun 2024

Physical activity significantly reduces all-cause and cardiovascular mortality risks in older adults

Physical activity significantly reduces all-cause and cardiovascular mortality risks in older adults, especially those with low socioeconomic status.

25 Jun 2024

Adverse public health effects of air pollution on global population

Exposure to high levels of air pollution can cause various health outcomes.

25 Jun 2024

Using real-world data to assess medication-related liver toxicity

The current method for assessing medication-related liver injury is not providing an accurate picture of some medications' toxicity - or lack thereof - to the liver, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

25 Jun 2024